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Abstract
OBJECTIVE—To update national population-level pregnancy-related mortality estimates and 
examine characteristics and causes of pregnancy-related deaths in the United States during 2011–
2013.
METHODS—We conducted an observational study using population-based data from the 
Pregnancy Mortality Surveillance System to calculate pregnancy-related mortality ratios by year, 
age group, and race–ethnicity groups. We explored 10 cause-of-death categories by pregnancy 
outcome during 2011–2013 and compared their distribution with those in our earlier reports since 
1987.
RESULTS—The 2011–2013 pregnancy-related mortality ratio was 17.0 deaths per 100,000 live 
births. Pregnancy-related mortality ratios increased with maternal age, and racial–ethnic disparities 
persisted with non-Hispanic black women having a 3.4 times higher mortality ratio than non-
Hispanic white women. Among causes of pregnancy-related deaths, the following groups 
contributed more than 10%: cardiovascular conditions ranked first (15.5%) followed by other 
medical conditions often reflecting pre-existing illnesses (14.5%), infection (12.7%), hemorrhage 
(11.4%), and cardiomyopathy (11.0%). Relative to the most recent report of Pregnancy Mortality 
Surveillance System data for 2006–2010, the distribution of cause-of-death categories did not 
change considerably. However, compared with serial reports before 2006–2010, the contribution of 
hemorrhage, hypertensive disorders of pregnancy, and anesthesia complications declined, whereas 
that of cardiovascular and other medical conditions increased (population-level percentage 
comparison).
CONCLUSION—The pregnancy-related mortality ratio and the distribution of the main causes of 
pregnancy-related mortality have been relatively stable in recent years.
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The risk of death during and shortly after pregnancy from pregnancy-related causes has not 
declined in the United States for more than 25 years.1 Data from the Centers for Disease 
Control and Prevention’s (CDC) Pregnancy Mortality Surveillance System show that the 
pregnancy-related mortality ratio has increased from approximately 10 deaths per 100,000 
live births in the early 1990s to 16 deaths per 100,000 live births for the aggregate period 
2006–2010.2 The same data document important, persistent racial–ethnic disparities in 
pregnancy-related mortality for greater than 20 years and suggest a continuing increasing 
contribution of chronic diseases, particularly cardiovascular disease, to mortality.2 Reasons 
for the reported increase in pregnancy-related mortality are not entirely clear, although 
improvements in the identification of these events—use of data linkages and of a pregnancy 
question (ie, checkbox) on the 2003 U.S. standard death certificate—were shown to have an 
important contribution (Creanga AA, Callaghan WM. Recent increases in the U.S. maternal 
mortality rate: disentangling trends from measurement issues [letter]. Obstet Gynecol 
2017;129:206–7).3,4
To provide the most recent national, population-level information regarding overall 
pregnancy-related mortality, causes of death, and populations at risk, we examine 
pregnancy-related mortality in the United States between 2011 and 2013, thus updating our 
previously published reports of aggregated 1987–2010 Pregnancy Mortality Surveillance 
System data.1,5–7
MATERIALS AND METHODS
We conducted an observational study using 2011–2013 data from the CDC’s Pregnancy 
Mortality Surveillance System. Fifty-two reporting areas (ie, 50 U.S. states, New York City, 
and Washington, DC) voluntarily submit to the CDC’s Division of Reproductive Health 
deidentified copies of death certificates for females 12–55 years who died during or within 1 
year of pregnancy from any cause; when available, linked birth or fetal death certificates are 
also sent. Additional sources of information for the Pregnancy Mortality Surveillance 
System include computerized searches of Lexis Nexis, reports by public health agencies, 
including state-based maternal mortality review committees, professional organizations, and 
individual health care providers. A clinically trained medical epidemiologist (C.S.) reviews 
all the information available for each death, determines the relationship between death and 
pregnancy, and the underlying cause of death. All information is reviewed again by a 
committee composed of the original reviewer and independent reviewers (A.A.C., W.M.C.) 
after initial data entry and cause-of-death determination to increase the consistency in 
ascertainment. A pregnancy-related death is defined as the death of a woman during or 
within 1 year of pregnancy that was caused by a pregnancy complication, a chain of events 
initiated by pregnancy, or the aggravation of an unrelated condition by the physiologic 
effects of pregnancy.1 The temporal association between the pregnancy status and death is 
ascertained with one or more of the following: the pregnancy checkbox on the death 
certificate indicating the woman was pregnant at the time of death or describing the interval 
between the end of a pregnancy and death; words or codes indicating a pregnancy on the 
death certificate; notes indicating the duration of complications causing or events leading to 
death on the death certificate; or availability of a birth or fetal death certificate within 1 year 
of the woman’s death. The causal association between the pregnancy status and death is 
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based on the clinical cause of death, the interval between the end of pregnancy and death, 
and the pathophysiology of pregnancy complications. Deaths attributable to a medical 
condition exacerbated by but not unique to pregnancy are not considered pregnancy-related 
if the temporal association between the pregnant status and death is known solely from a 
pregnancy checkbox stating “pregnant within a year”; if the checkbox states “pregnant 
within 42 days” or “pregnant within 90 days,” the death may be considered pregnancy-
related or not depending on the cause of death and the pathophysiologic relationship 
between the cause and pregnancy.
Coding for the Pregnancy Mortality Surveillance System is based on a system developed in 
1986 by the American College of Obstetricians and Gynecologists and the CDC Maternal 
Mortality Study Group. A 10-group cause-of-death classification including hemorrhage, 
infection, amniotic fluid embolism, thrombotic pulmonary or other embolism, hypertensive 
disorders of pregnancy, anesthesia complications, cerebrovascular accidents, 
cardiomyopathy, cardiovascular disease, and other noncardiovascular medical conditions is 
used for cause-of-death reporting. For each pregnancy-related death, the Pregnancy 
Mortality Surveillance System database includes the pregnancy outcome, associated medical 
conditions, and demographic and obstetric variables available in vital records.
For this analysis, maternal age was categorized as 19 or younger, 20–24, 25–29, 30–34, 35–
39, or 40 years or older; race–ethnicity was categorized as non-Hispanic white, non-
Hispanic black, Hispanic, or other; nativity or country of birth was categorized as U.S.- or 
foreign-born; maternal education was categorized as less than 12, 12, or greater than 12 
completed years; marital status was categorized as married or living together or unmarried; 
pregnancy outcomes were grouped as undelivered, induced or spontaneous abortion, live 
birth, stillbirth, ectopic pregnancy, molar pregnancy, or unknown; and timing of death was 
categorized as: before delivery, day of delivery (0 days), 1–6, 7–41, 42–182, or 183–364 
days postpartum. Data on race and ethnicity were missing for five women; in these women, 
race–ethnicity was assigned according to the predominant racial–ethnic group for the 
birthing population of women in the state where the woman died during the year of her 
death. Gestational trophoblast disease was the recorded pregnancy outcome for only one 
death during the period; in line with our previous Pregnancy Mortality Surveillance System 
report,2 for analysis purposes, we included this case in the undelivered category. Information 
on whether the woman was obese may be noted on death certificates as a contributing cause 
of death or may be obtained by calculating the prepregnancy body mass index {BMI, 
calculated as weight [kg]/[height (m)]2} using the woman’s height and prepregnancy weight 
recorded on the birth certificate; a woman with a BMI greater than 30 was considered 
obese.8
We calculated pregnancy-related mortality ratios (number of pregnancy-related deaths per 
100,000 live births) for the 2011–2013 period by year and age group for the four race–
ethnicity groups of interest. Denominator data (ie, live births) are from National Center for 
Health Statistics births reports.9–11 Analysis of cause-of-death data involved two steps: we 
first examined causes of pregnancy-related death by pregnancy outcome during 2011–2013 
and then calculated proportionate maternal mortality (ie, specific cause of death as a 
percentage of all pregnancy-related deaths) to explore changes in causes of pregnancy-
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related deaths since 1987 using previously published Pregnancy Mortality Surveillance 
System data. All analyses, including χ2 or Fisher exact tests, used to compare women’s 
sociodemographic by racial–ethnic groups were conducted using STATA 14. Pregnancy 
Mortality Surveillance System data do not include any personal identifiers; thus, the CDC’s 
institutional review board deemed the study as research not involving human subjects.
RESULTS
Data for 5,259 potential pregnancy-related deaths occurring between 2011 and 2013 were 
received by the CDC. Of these, 2,009 were found to be pregnancy-related (meeting both 
temporal and causal relationships with pregnancy), 3,131 were pregnancy-associated but not 
pregnancy-related (meeting only the temporal, not the causal relationship with pregnancy), 
and 62 were not pregnancy-associated (occurring more than 1 year after the end of 
pregnancy); for 57 women, neither the temporal nor the causal relationship between the 
death and pregnancy was met. This report is restricted to the 2,009 pregnancy-related deaths 
occurring in the United States during 2011–2013. Annual population-level pregnancy-
related mortality ratios were 17.8 deaths per 100,000 live births in 2011, 15.9 deaths per 
100,000 live births in 2012, and 17.3 deaths per 100,000 live births in 2013; the 
corresponding ratio for the 2011–2013 period was 17.0 deaths per 100,000 live births (Fig. 
1).
Forty percent of all pregnancy-related deaths during the period were among non-Hispanic 
white women, 37.9% among non-Hispanic black women, and 14.9% among Hispanic 
women, with few year-to-year differences (Table 1). For the 3-year period, specific race–
ethnicity pregnancy-related mortality ratios were 12.7, 43.5, 11.0, and 14.4 deaths per 
100,000 live births for non-Hispanic white, non-Hispanic black, Hispanic, and women of 
other races, respectively (Fig. 1). The ratio of the pregnancy-related mortality ratios between 
non-Hispanic black and non-Hispanic white women during 2011–2013 was 3.4 with an 
annual range between 3.2 (in 2013) and 3.6 (in 2012). Of all pregnancy-related deaths, 
16.1% of deaths were in foreign-born women. More than half of Hispanic women (53.9%) 
and women of other races (55.5%) dying from pregnancy complications during this period 
were foreign-born compared with only 3.1% of non-Hispanic white and 8.2% of non-
Hispanic black women.
Three in 10 (30.9%) women who died from pregnancy-related conditions during the study 
period were older than 35 years of age (Table 1). Pregnancy-related mortality ratios 
increased with maternal age for all women, but, within age groups, non-Hispanic black 
women 40 years of age and older had the highest risk of dying from pregnancy 
complications (192 deaths per 100,000 live births; Fig. 1). Over the 2011–2013 period, the 
risk ratio for death among non-Hispanic black compared with non-Hispanic white women 
was lowest among teenagers (2:1), increased continuously with age reaching its peak among 
women in their 30s (4.8:1), and was slightly lower for women 40 years or older (3.6:1).
Among women who died from pregnancy-related conditions, a significantly higher 
proportion of Hispanic than non-Hispanic women had less than 12 years of education and a 
significantly lower proportion of non-Hispanic black women than women in any other race 
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group were married (both P<.05; Table 1). Notably, approximately 18% of non-Hispanic 
white and black women were obese compared with 12.4% of Hispanic and 9.5% of other 
race women (Table 1). Of the 766 women with pregnancy-related deaths for whom the onset 
of prenatal care was known, 65 (8.5%) had not received any prenatal care and 188 (24.5%) 
started pre-natal care in their second or third trimester (data not shown).
Pregnancy outcomes were known for approximately 90% of pregnancy-related deaths (Table 
1). Slightly more than one fourth (26.5%) of women were undelivered, more than half 
(53.7%) had a live birth, 4.9% a stillbirth, 2.7% an ectopic pregnancy, and 2.4% an induced 
or spontaneous abortion; one woman in our series was reported to have died after gestational 
trophoblastic disease. The timing of death in relation to the end of the pregnancy was known 
for 86.8% (n=1,743) of all women with pregnancy-related deaths during the 2011–2013 
period (data not shown). Among these women, 532 (30.5%) died before delivery, 293 
(16.8%) on the day of delivery or pregnancy termination, 317 (18.2%) between 1 and 6 days 
postpartum, and 372 (21.3%) between 7 and 41 days postpartum; only 229 (13.2%) died on 
or after 42 days postpartum. This latter proportion ranged between 7.4% among Hispanic 
and 14.6% among non-Hispanic black women.
Of the 10 groups of causes of death, the following contributed more than 10% of all 
pregnancy-related deaths during the period of study: cardiovascular conditions ranked first 
(15.5%) followed by other noncardiovascular medical conditions (14.5%), infection 
(12.7%), hemorrhage (11.4%), and cardiomyopathy (11.0%); the other groups of causes of 
death contributed between 0.2% and 9.2% (Table 2). Of note, cardiovascular conditions, 
cardiomyopathy, and other medical conditions contributed 40.9% and 46.8% of pregnancy-
related deaths among non-Hispanic white and black women, respectively, but only 25.5% 
among women of other races and 31.3% among Hispanic women. Conversely, 39.5% of 
pregnancy-related deaths among Hispanic and 48.9% among other race women were 
attributable to hemorrhage, infection, and hypertensive disorders of pregnancy (data not 
shown).
The most common causes of death varied by pregnancy outcome. Among deaths after a live 
birth, thromboembolism, cardiomyopathy, and other cardiovascular conditions were the 
three most common causes of death, whereas hemorrhage, other noncardiovascular medical 
conditions, and infection were most commonly found with deaths after a stillbirth. Because 
42 days postpartum represents the cutoff for the World Health Organization’s definition of 
maternal death12 as opposed to 1 year in our definition of pregnancy-related death, we used 
our data with known information on timing of death to examine which causes of death 
would be more likely under-counted using the former definition. Among the 1,743 women 
with a known interval between the end of pregnancy and death, 1,514 (86.9%) died during 
pregnancy or within 42 days of the end of pregnancy. Almost all pregnancy-related deaths 
from hemorrhage, hypertensive disorders of pregnancy, and amniotic fluid embolism 
occurred within 42 days postpartum (98.7%, 96.8%, and 100.0%, respectively). However, a 
considerable proportion of deaths attributable to the remaining cause-of-death groups 
occurred after 42 days—9.9% of deaths attributable to each thrombotic pulmonary embolism 
and infection, 17.0% of cerebrovascular accident deaths, 20.5% of cardiovascular condition 
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deaths, 32.0% of other noncardiovascular medical condition deaths, and 55.2% of 
cardiomyopathy deaths.
We compared proportionate maternal mortality (ie, percentage of all pregnancy-related 
deaths) by cause of death for five time periods: 1987–1990, 1991–1997, 1998–2005, 2006–
2010, and 2011–2013, corresponding to previously published reports of Pregnancy Mortality 
Surveillance System data (Fig. 2). Relative to the 2006–2010 data, proportionate mortality 
by cause of death did not change considerably at the population level in 2011–2013, yet 
compared with data before the 2006–2010 period, at the population level, the contribution of 
hemorrhage, hypertensive disorders of pregnancy, and anesthesia complications declined, 
whereas that of cardiovascular, cerebrovascular accidents, and other medical conditions 
increased.
DISCUSSION
This analysis used national, population-level data to examine 2011–2013 pregnancy-related 
deaths in the United States. The pregnancy-related mortality ratio exhibited relative stability 
with 16–17 deaths per 100,000 live births since 2008.1 The observed leveling of the trend 
may be the result of most states having adopted the new versions of death certificates 
including the pregnancy checkbox.3 During 2011–2013, less than 15% of births were to 
women 35 years or older,9–11 but 30% of pregnancy-related deaths were in this age group. 
Increasingly more pregnant women in the United States have chronic health conditions13–15 
and are overweight or obese16,17; these conditions put pregnant women, especially those 40 
years of age and older, at higher risk of adverse outcomes.1,2 Among 2011–2013 pregnancy-
related deaths, 16.9% were in women for which prepregnancy obesity was recorded on vital 
statistics. We report obesity information given our higher confidence in the quality of this 
information in vital statistics data17,18 and the increasing attention from professional 
organizations on the management of obese pregnant women.8 Obesity information may be 
missing in our data, especially so for woman who died undelivered (no birth certificate). 
However, with one in six deaths in women whom we know were obese before pregnancy, 
there is need for health care providers to carefully consider the specific needs of pregnant 
obese women.
As per earlier Pregnancy Mortality Surveillance System reports,5,6 the contribution of 
traditional causes of pregnancy-related mortality (hemorrhage, hypertensive disorders of 
pregnancy, thromboembolism) continued to decline, whereas that of cardiovascular and 
other medical conditions increased. For both 2006–2010 and 2011–2013 periods in our 
reports, cardiovascular conditions, including cardiomyopathy, were responsible for 
approximately 26% of all pregnancy-related deaths.2 This proportion translates to a 
cardiovascular-specific pregnancy-related mortality ratio of 4.2 deaths per 100,000 live 
births in 2006–20101 and 4.8 deaths per 100,000 live births during 2011–2013. By 
comparison, although cardiovascular conditions were also the main cause of maternal 
mortality in the United Kingdom during the 2012–2014 period, the cardiovascular-specific 
maternal mortality ratio was 2 per 100,000 live births.19 Addressing cardiovascular disease 
in pregnancy requires early identification of disease, ideally before pregnancy, and 
continuous, risk-appropriate specialist care and follow-up throughout the pregnancy. Notable 
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differences from the preceding Pregnancy Mortality Surveillance System report2 are the 
decline in proportionate mortality from hypertensive disorders of pregnancy (9.4% in 2006–
2010 compared with 7.4% in 2011–2013) and infection (13.6% during 2006–2010 compared 
with 12.7% in 2011–2013). The latter is the result of fewer influenza-related deaths in 2011–
2013 than 2006–2010 when the 2009 H1N1 pandemic disproportionally affected pregnant 
women.20,21
Racial–ethnic disparities in pregnancy-related mortality persisted during 2011–2013—non-
Hispanic black women had a 3.4 times higher risk of dying from pregnancy complications 
than non-Hispanic white women. Our data also showed that half of Hispanic and other race 
women who died from pregnancy complications were foreign-born. These findings highlight 
the need to better understand how social determinants of health and barriers to risk-
appropriate care can be addressed to promote optimal outcomes for all women.
Pregnancy Mortality Surveillance System data have limitations. Because pregnancy-related 
deaths are relatively rare events, their identification may still be incomplete. On the other 
hand, in our review of Pregnancy Mortality Surveillance System data in recent years, we 
have observed the marking of the pregnancy checkbox among women older than 45 years 
even in the absence of documentation of pregnancy status on death certificates. Although 
this may indicate a group of women with very high-risk pregnancies, the possibility of 
misclassification of deaths, also noted by others,22 cannot be excluded. Linkages of maternal 
death and birth or fetal death certificate data can be done regularly by states in an effort to 
validate the checkbox information to the extent possible. Even if the Pregnancy Mortality 
Surveillance System is the most comprehensive source of national maternal mortality data 
and its 10-category cause-of-death system is more granular than International Classification 
of Diseases, 10th Revision codes, it contains limited information for understanding 
modifiable contributors to pregnancy-related mortality. With more than half of U.S. states 
now having functional maternal mortality review committees, state-level data and reports of 
maternal mortality can be used in tandem with the Pregnancy Mortality Surveillance System 
data to provide specific, data-driven recommendations to prevent future maternal deaths. 
Although not all maternal deaths are preventable, obstetricians should be familiar with 
current levels and causes of pregnancy-related deaths in the United States. Collaborative 
efforts such as those between the California Department of Public Health and the California 
Maternal Quality Care Collaborative demonstrate the promise that reviewing maternal 
deaths for the purpose of taking action can reduce the risk of women dying from 
complications of pregnancy.23 Reviews of severe maternal morbidity can complement the 
information obtained from maternal mortality reviews and improve our understanding of 
factors leading to adverse maternal events.24
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Figure 1. 
Population-level pregnancy-related mortality ratios by age, race–ethnicity, and overall for 
2011–2013. Results are population-level and can be compared as absolute values.
Creanga. Pregnancy-Related Mortality in the United States. Obstet Gynecol 2017.
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Figure 2. 
Population-level, cause-specific proportionate pregnancy-related mortality for 1987–1990, 
1991–1997, 1998–2005, 2006–2010, and 2011–2013. Results are population-level and can 
be compared as absolute values.
Creanga. Pregnancy-Related Mortality in the United States. Obstet Gynecol 2017.
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